Mode
Text Size
Log in / Sign up
N/A Completed N=106 Randomized Treatment

Suture Closure AFtEr VEIN Access for Cardiac Procedures (SAFE-VEIN) Trial

Atrial Fibrillation · atrial flutter · Heart Failure · Pulmonary Embolism and Thrombosis
Source: ClinicalTrials.gov NCT04632641 ↗
Enrolled (actual)
106
Serious AEs
10.0%
Results posted
May 2024
Primary outcomePrimary: Time to Achieve Hemostasis — 7; 11 Minutes

Summary

Primary objective: To compare the safety and efficacy of closure strategies post venous access procedures. Hypothesis: We anticipate that the use of a venous closure device will decrease the time to hemostasis (TTH), time to ambulation (TTA) and time to discharge (TTD) compared to conventional methods of closure following venous access procedure.

Outcome Measures

OutcomeResultp-value
PRIMARY
Time to Achieve Hemostasis
7; 11
PRIMARY
Time to Ambulate
322; 403
SECONDARY
Time to Discharge (TTD)/Length of Stay (LOS)
1257; 1338
SECONDARY
Post Procedure Major Bleeding
0; 0
SECONDARY
Minor Bleeding
5; 4
SECONDARY
Access Site Complications
0; 2
SECONDARY
Mortality
0; 0

Eligibility Criteria

Inclusion criteria

Large-bore (>13F) Venous Access Procedures Inclusion Criteria:

All patients 18 years and older who are undergoing any of the following: WATCHMAN® device placement, atrial fibrillation ablation using cryoballoon or laser balloon, leadless pacemaker, Pulmonary embolism thrombectomy (Inari FlowTriever system), MitraClip transcatheter mitral valve repair at Aurora St. Luke's Medical Center from date of IRB (Institutional Review Board) approval through December 2022. All arterial line access should be radial.

Exclusion criteria

Large-bore (>13F) Venous Access Procedures Exclusion Criteria:

  • Patients in whom introducer sheaths >25F were used in the vein during the catheterization procedure.
  • Patients with small femoral arteries or veins ( 40 kg/m2) or underweight (BMI < 20 kg/m2)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04632641). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search